singulair
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.34 | $100.12 (0%) | 🛒 Add to cart |
| 60 | $2.50 | $200.24 $150.18 (25%) | 🛒 Add to cart |
| 90 | $2.22 | $300.36 $200.24 (33%) | 🛒 Add to cart |
| 120 | $2.09 | $400.48 $251.30 (37%) | 🛒 Add to cart |
| 180 | $1.95 | $600.71 $351.42 (41%) | 🛒 Add to cart |
| 270 | $1.86
Best per pill | $901.07 $502.60 (44%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.40 | $42.05 (0%) | 🛒 Add to cart |
| 60 | $1.15 | $84.10 $69.08 (18%) | 🛒 Add to cart |
| 90 | $1.08 | $126.15 $97.12 (23%) | 🛒 Add to cart |
| 120 | $1.04 | $168.20 $125.15 (26%) | 🛒 Add to cart |
| 180 | $1.00 | $252.30 $180.21 (29%) | 🛒 Add to cart |
| 270 | $0.98 | $378.45 $263.31 (30%) | 🛒 Add to cart |
| 360 | $0.96
Best per pill | $504.60 $346.41 (31%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.37 | $71.08 (0%) | 🛒 Add to cart |
| 60 | $1.89 | $142.17 $113.13 (20%) | 🛒 Add to cart |
| 90 | $1.74 | $213.25 $156.19 (27%) | 🛒 Add to cart |
| 120 | $1.65 | $284.34 $198.24 (30%) | 🛒 Add to cart |
| 180 | $1.57 | $426.51 $283.34 (34%) | 🛒 Add to cart |
| 270 | $1.52
Best per pill | $639.76 $411.49 (36%) | 🛒 Add to cart |
Synonyms
| |||
Montelukast sodium, a selective leukotriene receptor antagonist, represents one of those rare pharmaceutical innovations that fundamentally shifted how we approach chronic inflammatory airway diseases. When I first encountered this compound during my pulmonary fellowship back in 2002, the prevailing attitude was skeptical - another “me-too” asthma drug, we thought. But watching Mrs. Gable, a 62-year-old with corticosteroid-dependent asthma who’d been hospitalized three times that year, transition to montelukast and successfully taper off prednisone entirely within four months… that’s when I understood we were dealing with something different.
Singulair: Targeted Asthma and Allergy Control Through Leukotriene Pathway Inhibition
1. Introduction: What is Singulair? Its Role in Modern Medicine
Singulair contains montelukast sodium as its active pharmaceutical ingredient, classified pharmacologically as a leukotriene receptor antagonist. What is Singulair used for? Primarily, it addresses the underlying inflammatory pathways in asthma and allergic rhinitis, offering a non-steroidal alternative for chronic management. The significance of Singulair in clinical practice stems from its unique mechanism - unlike bronchodilators that provide immediate symptom relief or corticosteroids that broadly suppress inflammation, montelukast specifically targets the cysteinyl leukotriene pathway. I remember our hospital’s formulary committee debate about whether Singulair warranted the substantial cost difference compared to older antihistamines - Dr. Chen argued passionately that we were paying for precision, not just another antihistamine.
2. Key Components and Bioavailability of Singulair
The composition of Singulair revolves around montelukast sodium, which is formulated as the amorphous form to enhance dissolution characteristics. The standard release forms include 4mg and 5mg chewable tablets for pediatric populations, 10mg film-coated tablets for adults, and 4mg oral granules for younger children who cannot swallow tablets. Bioavailability of Singulair approaches 64% for the oral formulation, with peak plasma concentrations occurring 3-4 hours post-administration in fasting state. The absorption isn’t significantly affected by food, though we typically recommend consistent timing relative to meals for adherence purposes. The chewable formulations contain phenylalanine, which created a memorable learning moment early in my practice when I prescribed it to a child with PKU without checking - caught by an alert pharmacist, thank goodness.
3. Mechanism of Action of Singulair: Scientific Substantiation
Understanding how Singulair works requires diving into the arachidonic acid cascade. When mast cells and eosinophils activate in allergic responses, they convert arachidonic acid to leukotrienes via 5-lipoxygenase. Specifically, leukotriene C4, D4, and E4 (the cysteinyl leukotrienes) bind to CysLT1 receptors in airway smooth muscle and inflammatory cells. Montelukast competitively antagonizes these receptors, preventing the bronchoconstriction, vascular permeability, and inflammatory cell recruitment that would otherwise occur. The effects on the body are measurable within hours of the first dose, though clinical benefits typically accumulate over weeks. I’ve used this analogy with medical students: if histamine is the shouting alarm in allergic reactions, leukotrienes are the persistent background noise that maintains chronic inflammation - and Singulair specifically turns down that background noise.
4. Indications for Use: What is Singulair Effective For?
Singulair for Asthma
The primary indication remains chronic asthma management, particularly in patients with demonstrated allergic components. The beautiful thing about Singulair for asthma is its steroid-sparing potential - I’ve weaned countless patients off oral corticosteroids, sometimes completely, often substantially reducing their dose. The clinical evidence strongly supports its use as add-on therapy in inadequately controlled asthma, though I’ve found it works remarkably well as monotherapy in mild persistent cases, especially in children hesitant about inhalers.
Singulair for Allergic Rhinitis
For seasonal and perennial allergic rhinitis, Singulair provides comprehensive symptom control, though with a different temporal pattern than antihistamines. Where antihistamines work within hours for sneezing and rhinorrhea, Singulair particularly shines for nasal congestion relief, which develops more gradually but persists consistently. I had a college student, Marcus, whose exam performance improved dramatically once we controlled his perennial rhinitis with nightly montelukast - he’d been struggling with chronic sleep disruption from nasal obstruction that neither antihistamines nor nasal steroids had fully addressed.
Singulair for Exercise-Induced Bronchoconstriction
The prevention of exercise-induced bronchoconstriction represents another key application, with dosing recommended 2 hours before anticipated exertion. This has been transformative for young athletes - I follow a competitive swimmer who went from needing albuterol before every practice to using montelukast preventively and rarely touching her rescue inhaler.
5. Instructions for Use: Dosage and Course of Administration
The instructions for use of Singulair emphasize consistency - same time daily, typically in the evening for asthma (coinciding with natural dips in lung function) or as directed for allergic rhinitis. The standard dosage follows this pattern:
| Indication | Age Group | Dosage | Timing |
|---|---|---|---|
| Asthma | Adults 15+ | 10mg | Once daily, evening |
| Asthma | Children 6-14 | 5mg chewable | Once daily, evening |
| Asthma | Children 2-5 | 4mg chewable or granules | Once daily, evening |
| Allergic Rhinitis | Adults 15+ | 10mg | Once daily, anytime |
| Exercise-Induced | Adults 15+ | 10mg | At least 2 hours before exercise |
The course of administration is continuous for chronic conditions, not intermittent. Side effects are generally mild - headache and gastrointestinal upset being most common in my experience, though the neuropsychiatric concerns have certainly made us more cautious in recent years.
6. Contraindications and Drug Interactions with Singulair
Contraindications for Singulair are relatively few but important: known hypersensitivity to montelukast or any component, and caution in patients with pre-existing neuropsychiatric conditions. The safety during pregnancy category B designation means we weigh benefits against theoretical risks - I’ve continued it in pregnant asthmatics where the alternative was poorly controlled asthma, which carries its own fetal risks.
Drug interactions with Singulair are minimal due to its metabolism through CYP450 pathways without significant inhibition or induction. However, I did observe one interesting case where phenobarbital appeared to reduce montelukast levels in an epileptic patient - we confirmed this through levels and adjusted timing, achieving better control. The interactions with other asthma medications are generally favorable, with additive benefits observed with inhaled corticosteroids and no concerning pharmacokinetic interactions.
7. Clinical Studies and Evidence Base for Singulair
The scientific evidence for Singulair spans decades now, with the initial landmark studies published in NEJM and AJRCCM in the late 1990s. A meta-analysis in Chest (2010) demonstrated consistent improvement in asthma control scores and reduction in exacerbation rates. The effectiveness appears most pronounced in specific phenotypes - patients with elevated urinary leukotriene E4, aspirin-exacerbated respiratory disease, and those with prominent allergic components.
What surprised me in the real-world data was the durability of response - I’ve followed patients on montelukast for over 15 years with maintained benefit, something we didn’t necessarily anticipate from the initial 12-week trials. The physician reviews in our pulmonary department consistently rate it as valuable, particularly for its oral route and pediatric applicability.
8. Comparing Singulair with Similar Products and Choosing Quality Medication
When comparing Singulair with similar products, the distinction lies in its specific mechanism within the leukotriene modifier class. Zileuton inhibits 5-lipoxygenase upstream, while montelukast blocks the receptor downstream. In practical terms, zileuton requires liver monitoring and four-times-daily dosing, making montelukast generally preferable for chronic use.
The generic montelukast products have largely demonstrated bioequivalence, though I’ve noticed occasional patients who report differences - whether perceptual or actual is hard to determine. Which Singulair formulation is better depends on patient factors: the granules for young children, chewables for those who struggle with pills, standard tablets for everyone else. How to choose comes down to individual patient characteristics, phenotype, and practical considerations like cost and adherence.
9. Frequently Asked Questions (FAQ) about Singulair
What is the recommended course of Singulair to achieve results?
Most patients notice some benefit within the first week, but maximal effect typically requires 4-6 weeks of consistent use. We generally recommend a 3-month trial to properly assess response before considering discontinuation.
Can Singulair be combined with antihistamines?
Absolutely - in fact, they’re often complementary. Antihistamines address the early-phase allergic response, while Singulair modifies the later, leukotriene-mediated phase. Many of my patients with significant allergic disease use both, particularly during peak allergy seasons.
Is weight gain associated with Singulair?
Unlike corticosteroids, montelukast hasn’t demonstrated consistent weight effects in clinical trials. In my practice, I haven’t observed a signal either - if anything, some patients lose weight indirectly through improved activity tolerance.
Why is Singulair dosed in the evening for asthma?
Asthma symptoms frequently worsen overnight due to natural circadian rhythms in inflammation and bronchial reactivity. Evening dosing provides peak drug levels during this vulnerable period.
10. Conclusion: Validity of Singulair Use in Clinical Practice
The risk-benefit profile of Singulair remains favorable for appropriate patients, particularly those with demonstrated leukotriene-mediated disease. While the neuropsychiatric concerns have rightfully prompted more cautious prescribing and monitoring, the majority of patients tolerate it well and derive meaningful clinical benefit.
Looking back over two decades of using this medication, I’m struck by how our understanding has evolved - from initial skepticism to widespread adoption, then to more nuanced application as we recognized both its strengths and limitations. The validity of Singulair in clinical practice rests on its targeted mechanism, oral convenience, and proven efficacy in specific asthma and allergy phenotypes.
I’m still following that first patient I mentioned, Mrs. Gable - she’s 82 now, still on her nightly montelukast, still gardening and traveling with her grandchildren. At her last visit, she reminded me of our initial conversation in 2003 when she’d asked, “Will this really let me breathe normally again?” Twenty years later, the answer remains yes - with the important caveat that we monitor for any mood changes and maintain open communication about both benefits and potential risks. That’s the art of medicine - not just prescribing, but partnering with patients through their entire journey with these medications.